GEHC vs GEN

Key Takeaways

• GE HealthCare Technologies (GEHC) has faced headwinds from inflation and supply chain costs, leading to a recent profit guidance cut and YTD declines of around 26%.
• Gen Digital (GEN), a cybersecurity firm, shows stronger YTD performance at about 27% gains earlier in the year but has pulled back, with 1-year returns around 22%.
• GEHC trades at a forward P/E of approximately 12.5x with steady revenue growth of 3-4%, while GEN offers a higher dividend yield of 2.5% and AI-driven product momentum.
• Both stocks lag broader market indices like the S&P 500 over the past year, but GEN demonstrates better relative stability in recent market activity.
• Sector contrasts highlight GEHC's exposure to medical devices amid cost pressures versus GEN's subscription-based cybersecurity resilience.

Introduction

This stock comparison between GE HealthCare Technologies (GEHC) and Gen Digital (GEN) evaluates their relative performance, business models, and market positioning in the current environment. GEHC, a leader in medical imaging and diagnostics, contrasts with GEN, provider of consumer cybersecurity solutions like Norton. Traders seeking sector diversification or investors eyeing healthcare versus technology defensives may find value in analyzing their recent momentum, growth drivers, and risk profiles. With both underperforming broader indices amid volatility, this analysis highlights key trade-offs in stability and upside potential.

GEHC Overview and Recent Performance

GE HealthCare Technologies (GEHC) develops medical technologies, including imaging systems, ultrasound, patient monitoring, and pharmaceutical diagnostics. In recent quarters, the company reported revenue growth of around 5%, reaching $20.6 billion annually, driven by segments like Pharmaceutical Diagnostics with double-digit gains. However, recent market activity has pressured shares, down approximately 26% YTD and 10-14% over the past year, underperforming the S&P 500. A Q1 earnings report highlighted revenue beats but a profit guidance cut due to inflation in memory chips, oil, and freight, alongside tariff impacts estimated at $250 million. This led to a sharp 13% single-day drop, reflecting sentiment shifts from cost pressures and segment reorganization combining imaging units. Despite a record $21.8 billion backlog and innovations like AI-enabled cardiology tools, shares trade near $61 with a forward P/E of 12.5x, suggesting potential value if headwinds ease.

GEN Overview and Recent Performance

Gen Digital (GEN) provides cyber safety solutions through brands like Norton and Avast, focusing on subscriptions for individuals and small businesses. Recent quarters showed robust revenue growth of 26% to $1.24 billion in Q3 FY26, with raised full-year guidance amid strong demand for AI-native products like VPNs and scam protection. Shares have exhibited resilience, posting YTD gains around 27% earlier before moderating, with 1-year returns near 22%, outperforming GEHC but trailing the S&P 500. Partnerships with xAI for AI assistants and Microsoft for financial insights bolster sentiment, alongside 28 cybersecurity awards. Trading near $20 with a forward P/E of 6.5x and 2.5% dividend yield, GEN's subscription model offers recurring revenue stability, though YTD pullbacks reflect broader tech sector rotations.

Trending AI Robots

Tickeron’s Trending AI Robots page features a curated selection of over 25 high-performing AI trading bots out of more than 351 total bots available on the platform. These bots, powered by advanced AI models, trade thousands of tickers across stocks, ETFs, and crypto in dynamic sectors like semiconductors, industrials, energy, and finance, adapting to current market conditions with strategies ranging from momentum to sector rotation. Standout stats include annualized returns from 23% to 162%, win rates of 51% to 88%, and profit factors up to 11.7, often beating the S&P 500 with drawdowns managed effectively. For instance, semiconductor-focused bots on NVDA and AVGO show 69% returns at 60% win rates, while multi-ticker industrials deliver 93% annualized gains. Traders can explore signal agents for real-time alerts or virtual agents with risk controls—no minimum balance required. Visit Trending AI Robots to review these top performers and subscribe for copy trading opportunities tailored to today's volatility.

Head-to-Head Comparison

GEHC and GEN operate in distinct sectors: healthcare technology versus cybersecurity software. GEHC's capital-intensive model relies on equipment sales and services with a $21.8 billion backlog, but faces risks from supply chain inflation and tariffs, compressing margins to 13.5%. Growth drivers include AI imaging and diagnostics, yet recent momentum lags with -26% YTD versus GEN's more stable subscription revenue (41% operating margins). GEN benefits from recurring cyber demand and AI integrations, offering lower volatility (beta 1.09) and a dividend, though exposed to consumer spending shifts. Market sentiment favors GEN's 22% 1-year return over GEHC's -12%, highlighting trade-offs in growth consistency versus valuation appeal.

Tickeron AI Verdict

Tickeron’s AI currently favors Gen Digital (GEN) due to superior trend consistency, higher recent returns, and resilient subscription growth amid cybersecurity tailwinds. While GEHC offers attractive valuation and backlog stability, its cost pressures introduce higher near-term risks. Probabilistic edge leans toward GEN for momentum traders, though both warrant monitoring for sector rotations.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations